| Quarter | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| 28 | 33 | 37 | |
Growth YoY Revenue Growth YoY% | 32.7 | ||
| 22 | 28 | 31 | |
| 6 | 5 | 6 | |
OPM OPM% | 21.5 | 15.7 | 16.6 |
| 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 |
PBT PBTCr | 6 | 5 | 6 |
| 1 | 2 | 2 | |
| 4 | 3 | 4 | |
Growth YoY PAT Growth YoY% | -1.4 | ||
NPM NPM% | 15.1 | 8.3 | 11.2 |
| 7.1 | 3.4 | 5.8 |
| Quarter | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| 28 | 33 | 37 | |
Growth YoY Revenue Growth YoY% | 32.7 | ||
| 22 | 28 | 31 | |
| 6 | 5 | 6 | |
OPM OPM% | 21.5 | 15.7 | 16.6 |
| 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 |
PBT PBTCr | 6 | 5 | 6 |
| 1 | 2 | 2 | |
| 4 | 3 | 4 | |
Growth YoY PAT Growth YoY% | -1.4 | ||
NPM NPM% | 15.1 | 8.3 | 11.2 |
| 7.1 | 3.4 | 5.8 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 24 | 35 | 36 | 50 | 61 | 70 |
Growth Revenue Growth% | 49.1 | 0.5 | 41.3 | 20.6 | ||
| 20 | 32 | 27 | 40 | 50 | 58 | |
| 4 | 3 | 8 | 11 | 11 | 11 | |
OPM OPM% | 15.1 | 9.2 | 23.7 | 21.4 | 18.4 | 16.2 |
| 0 | 0 | 0 | 0 | 0 | 1 | |
Interest Expense Interest ExpenseCr | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 |
PBT PBTCr | 1 | 2 | 7 | 9 | 10 | 11 |
| 1 | 0 | 2 | 3 | 3 | 3 | |
PAT PATCr | 0 | 1 | 5 | 6 | 7 | 7 |
Growth PAT Growth% | 151.0 | 335.8 | 15.9 | 11.4 | ||
NPM NPM% | 2.1 | 3.5 | 15.1 | 12.4 | 11.4 | 9.8 |
| 10.3 | 9.1 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 24 | 35 | 36 | 50 | 61 | 70 |
Growth Revenue Growth% | 49.1 | 0.5 | 41.3 | 20.6 | ||
| 20 | 32 | 27 | 40 | 50 | 58 | |
| 4 | 3 | 8 | 11 | 11 | 11 | |
OPM OPM% | 15.1 | 9.2 | 23.7 | 21.4 | 18.4 | 16.2 |
| 0 | 0 | 0 | 0 | 0 | 1 | |
Interest Expense Interest ExpenseCr | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 |
PBT PBTCr | 1 | 2 | 7 | 9 | 10 | 11 |
| 1 | 0 | 2 | 3 | 3 | 3 | |
PAT PATCr | 0 | 1 | 5 | 6 | 7 | 7 |
Growth PAT Growth% | 151.0 | 335.8 | 15.9 | 11.4 | ||
NPM NPM% | 2.1 | 3.5 | 15.1 | 12.4 | 11.4 | 9.8 |
| 10.3 | 9.1 |
| Financial Year | Mar 2026 | Sep 2026 |
|---|---|---|
Equity Capital Equity CapitalCr | 808 | 808 |
Reserves ReservesCr | 3,927 | 4,341 |
| 8,152 | 8,398 | |
| 8,152 | 8,398 |
| Financial Year | Mar 2026 | Sep 2026 |
|---|---|---|
Equity Capital Equity CapitalCr | 808 | 808 |
Reserves ReservesCr | 3,927 | 4,341 |
| 8,152 | 8,398 | |
| 8,152 | 8,398 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 |
|---|---|---|---|---|
| 5 | 3 | 0 | -16 | |
| 0 | -1 | 0 | -2 | |
| -5 | -3 | 0 | 21 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 3 |
Free Cash Flow Free Cash FlowCr | ||||
CFO To PAT CFO To PAT% | 1,010.2 | 272.4 | 5.2 | -237.3 |
CFO To EBITDA CFO To EBITDA% | 138.3 | 102.8 | 3.3 | -147.5 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2026 |
|---|---|---|---|---|
| 5 | 3 | 0 | -16 | |
| 0 | -1 | 0 | -2 | |
| -5 | -3 | 0 | 21 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 | 3 |
Free Cash Flow Free Cash FlowCr | ||||
CFO To PAT CFO To PAT% | 1,010.2 | 272.4 | 5.2 | -237.3 |
CFO To EBITDA CFO To EBITDA% | 138.3 | 102.8 | 3.3 | -147.5 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 75 | 128 | ||||
Price To Earnings Price To Earnings | 10.9 | 17.3 | ||||
Price To Sales Price To Sales | 1.2 | 1.8 | ||||
Price To Book Price To Book | 0.0 | 0.0 | ||||
EV To EBITDA EV To EBITDA | 172.3 | 174.8 | ||||
GPM GPM% | ||||||
OPM OPM% | 15.1 | 9.2 | 23.7 | 21.4 | 18.4 | 16.2 |
NPM NPM% | 2.1 | 3.5 | 15.1 | 12.4 | 11.4 | 9.8 |
ROCE ROCE% | 0.2 | 0.2 | ||||
ROE ROE% | 0.1 | 0.1 | ||||
ROA ROA% | 0.1 | 0.1 | ||||
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 75 | 128 | ||||
Price To Earnings Price To Earnings | 10.9 | 17.3 | ||||
Price To Sales Price To Sales | 1.2 | 1.8 | ||||
Price To Book Price To Book | 0.0 | 0.0 | ||||
EV To EBITDA EV To EBITDA | 172.3 | 174.8 | ||||
GPM GPM% | ||||||
OPM OPM% | 15.1 | 9.2 | 23.7 | 21.4 | 18.4 | 16.2 |
NPM NPM% | 2.1 | 3.5 | 15.1 | 12.4 | 11.4 | 9.8 |
ROCE ROCE% | 0.2 | 0.2 | ||||
ROE ROE% | 0.1 | 0.1 | ||||
ROA ROA% | 0.1 | 0.1 | ||||
| Market CapitalizationMkt CapCr | 1,812 | 230 | 149 | 128 | 123 | 90 | 80 |
| Close PriceClose₹ | 115.57 | 207.00 | 135.00 | 158.00 | 57.08 | 68.51 | 52.75 |
| IndustryIndustry | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS |
| Price To EarningsPE | 17.54 | 17.26 | 17.34 | 29.66 | 26.24 | ||
| Price To SalesPS | 0.66 | 2.28 | 1.09 | 1.83 | 4.58 | 0.93 | 1.23 |
| RevenueRevenueCr | 2,756 | 101 | 137 | 70 | 27 | 97 | 65 |
| Revenue Growth TTMRev Gr TTM% | -0.1% | 22.3% | 54.7% | -1.4% | 114.4% | ||
| PAT Growth TTMPAT Gr TTM% | -184.9% | 44.5% | -3.4% | 51.4% | 410.3% |
| Market CapitalizationMkt CapCr | 1,812 | 230 | 149 | 128 | 123 | 90 | 80 |
| Close PriceClose₹ | 115.57 | 207.00 | 135.00 | 158.00 | 57.08 | 68.51 | 52.75 |
| IndustryIndustry | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS |
| Price To EarningsPE | 17.54 | 17.26 | 17.34 | 29.66 | 26.24 | ||
| Price To SalesPS | 0.66 | 2.28 | 1.09 | 1.83 | 4.58 | 0.93 | 1.23 |
| RevenueRevenueCr | 2,756 | 101 | 137 | 70 | 27 | 97 | 65 |
| Revenue Growth TTMRev Gr TTM% | -0.1% | 22.3% | 54.7% | -1.4% | 114.4% | ||
| PAT Growth TTMPAT Gr TTM% | -184.9% | 44.5% | -3.4% | 51.4% | 410.3% |